-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy 2 For Oncology And Coronavirus Disease 2019 (COVID-19) in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cellular Immunotherapy 2 For Oncology And Coronavirus Disease 2019 (COVID-19) in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cellular Immunotherapy 2...
-
Product Insights
Nevoria Project
The Nevoria Project is a gold mine in Australia. It is currently in operation. Empower your strategies with our Nevoria Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital information...
-
Product Insights
Maogong Mine
The Maogong Mine is a iron ore mine in China. It is currently in operation. Empower your strategies with our Maogong Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital...
-
Product Insights
Aoniu Mine
The Aoniu Mine is a iron ore mine in China. It is currently in operation. Empower your strategies with our Aoniu Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital...
-
Company Profile
ImmunityBio Inc – Company Profile
ImmunityBio Inc (ImmunityBio), formerly NantKwest Inc, a clinical-stage biotechnology company is developing therapies and vaccines that complement, harness and amplify the immune system to defeat cancers and infectious diseases. The company product pipeline includes n-803 + bcg for bladder cancer, anktiva + pd-l1 t-hank for lung cancer, anktiva + aldox +pd-l1 t-hank for pancreatic cancer, her2 t-hank for glioblastoma and anktiva + m-cenk for advanced solid tumor. ImmunityBio Anktiva, a lead candidate Anktiva are a novel class of biopharmaceuticals that...
Add to Basket -
Company Profile
Harte Hanks Inc – Company Profile
Harte Hanks Inc (Harte Hanks) is a provider of integrated, omni-channel and data driven marketing services, logistics services and data management software. The company's offerings include data and analytics, creative services, database marketing solutions, direct mail, mail, print and product fulfillment, logistics, Consulting, Contact Center, Technical Support, Social Media Support and contact centers. Harte Hanks serves B2B, retail, consumer, finance, healthcare, travel and leisure, automotive, technology, entertainment, and insurance industries. It markets products and solutions through direct sales force and...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy 2 for Oncology and Coronavirus Disease 2019 (COVID-19)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Cellular Immunotherapy 2 for Oncology and Coronavirus Disease 2019 (COVID-19) Drug Details Cellular immunotherapy...